A total of 139 patients undergoing treatment for na?ve lung squamous cell carcinomas with tumor tissue samples available for testing were recruited.EGFR and KRAS mutation statuses of the tumor samples were detected using a mutant enriched liquid chip. The gene discussed is KRAS; the disease is squamous cell lung carcinoma.